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DObjective: Thromboembolism remains a serious complication during endovascular surgery. Commercially
available filter devices, which are unified with the stenting systems, provide short-time performance owing to
the adhesion of thrombus to the filters themselves. We have, therefore, developed a new detachable filter that
can be used in all major aortic branches and shows greater longevity. The present study assessed the efficacy
of the new detachable filter and examined the feasibility of deploying and retrieving the filters.
Methods:We first performed in vitro studies. Our experimental flow model used silicon tubing to simulate the
aortic branches. Polystyrene-divinylbenzene microspheres (100 and 200 mm in diameter), which simulated
embolic particles, were injected into the tubing after the detachable filter was deployed. The capture efficacy
(number of microspheres trapped in the detachable filter/total injected microspheres) was calculated. In the
in vivo studies, the detachable filters were implanted into the carotid, visceral, and renal arteries of 5 mongrel
dogs. Angiography was performed every 30 minutes. At 5 hours after implantation, each detachable filter was
retrieved by a gooseneck snare catheter.
Results: In the in vitro studies, our detachable filters showed high capture efficacy, capturing 99.2% of the
100-mm microspheres and 99.4% of the 200-mm microspheres. In the in vivo studies, all detachable filters
were successfully deployed into the major branches. Each angiographic study revealed smooth flow without
any embolic obstruction of the filter. At 5 hours after deployment, all devices were completely retrieved by
the snare catheter without aortic injury.
Conclusions: The new detachable filter showed high efficacy in capturing the particles. All detachable filters
were successfully deployed for 5 hours, and the filters were retrieved from the aortic branches without any com-
plications. This novel detachable filter can help prevent serious distal thromboembolism during endovascular
surgery. (J Thorac Cardiovasc Surg 2012;144:1399-403)Endovascular surgery, such as aortic stent grafting or
transcatheter aortic valve implantation, is emerging as an
alternative treatment of thoracic aortic aneurysms and aor-
tic stenosis in high-risk patients.1-5 However, distal embolic
events are major complications of these procedures.5-8
Distal protection filters are routinely used to prevent em-
bolic stroke in carotid artery stenting.9,10 Many studies have
demonstrated the effectiveness of these protective filters.11-14
However, their use is limited to stenting operations, because
they are combined with the stenting system. In addition, the
longevity of the filters is poor because of thrombus
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The Journal of Thoracic and CarTherefore, we developed a detachable intra-aortic filter
device with a new coating system to increase its durability.
We designed the detachable filters such that after deploy-
ment in the targeted aortic branches, the filters could
prevent distal thromboembolism during endovascular sur-
gery without hindering the main operation.
In the present study, we assessed the efficacy of our new
detachable filter and examined the feasibility of deploying
and retrieving the filters using the canine cerebral, visceral,
and renal arteries.METHODS
New Detachable Filter
Our novel device consists of a nickel–titanium frame with a polyester
mesh (Figure 1). The filter itself is composed of a polyester mesh with
a new antithrombogenic coating system that inhibits both the enzymatic
activity of thrombin and platelet adhesion (Toray Industries, Tokyo, Japan).
Each pore in the polyester mesh is 100 mm in diameter. The polyester yarn
is 27 mm in diameter. The mesh filter is mounted on a self-expandable
nickel–titanium frame to allow the filter to conform to the interior diameter
of each branch artery. The diameter of the frame ring is 8 mm, which is
designed to be 20% larger than the diameter of the canine aortic branches
at the landing zone of the filter device. The frame ring is connected to
a stainless steel shaft (0.15 mm in diameter) with 4 polyester threads. A
slidable polyimide sleeve is set over the stainless steel shaft, togetherdiovascular Surgery c Volume 144, Number 6 1399
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end is bent into a hook shape. A J-shaped spring coil is attached to the distal
tip of the shaft. The filter is preloaded in the delivery sheath, which is com-
posed of a 4.5F polytetrafluoroethylene sheath as attached to a 3F shaft. To
push out the filter from the delivery sheath, a 0.014-in. stainless steel wire
with a plate on its tip, designated the ‘‘pushing wire,’’ is put in advance in
the delivery sheath at a position just proximal to the hooked wire of the
preloaded filter.
Deployment and Retrieval of Detachable Filter
Device
To deploy the filter, a 6F sheath catheter (Johnson & Johnson, New
Brunswick, NJ) was inserted, and a 6F guiding catheter (Johnson & John-
son) was passed through the sheath catheter up to the thoracic aorta until its
distal end reached the targeted branch of the aorta. Next, the filter system
(the delivery sheath storing the preloaded filter and the pushing wire) was
introduced into the guiding catheter. Once the J-shaped spring coil tip
reached the end of the guiding catheter, its direction was adjusted by
wrenching the shaft of the delivery sheath such that it can help to guide
the filter system into the targeted artery. After the landing zone for the filter
was secured, the filter was released and opened successively by pulling
back the delivery sheath while the pushing wire was kept in place. The
6F guiding catheter, in which the delivery sheath and pushing wire had
been stored, was then removed from the 6F sheath catheter.
To retrieve the filter device smoothly, an Amplatz gooseneck snare (Mi-
crovena, White Bear Lake, Mich) was passed through a 4F catheter
(Figure 2) to grip the hooked wire at the end of the shaft of the filter.
The 4F catheter was then pushed up until it abutted the polyimide slidable
sleeve. The sleeve was then moved distally to gather the 4 polyester threads
along the shaft whereby the ring frame and the mesh of the filter were
folded inward. The completely folded filter was then withdrawn through
the 6F sheath catheter.
In Vitro Studies
The experimental flowmodel consisted of combined silicone tubing in 2
sizes: 1 with a 10-mm inner diameter to simulate the thoracic aorta and 1FIGURE 1. Schematic representation of the filter and the filter system.
1400 The Journal of Thoracic and Cardiovascular Surwith a 6-mm inner diameter to simulate an aortic branch such as the carotid
artery, renal artery, or visceral artery (Figure 3). A roller pump (Capiox,
SP-101; Terumo, Tokyo, Japan) was used to deliver a pulsatile flow (130
pulses/min) of 0.9% saline solution from a reservoir. The flow rate was
set to 1800 mL/min; the systolic pressures were measured using a system
for intra-arterial blood pressure monitoring (TruWave; Edwards-
Lifesciences, Irvine, Calif) and found to be 100 mm Hg. A polyethylene
mesh filter with a 53-mm width (Nytal; Sefar, Heiden, Switzerland) was
placed at the inflow side of the reservoir to capture the particles that passed
through the detachable filter.
Simulation of Thromboembolism
Polystyrene-divinylbenzene microspheres (EZ-TRAC; IMT Laborato-
ries, Irvine, Calif) with a diameter of 100 and 200 mm were used. The mi-
crospheres were preserved in 0.9% saline, and the numbers of the 100- and
200-mm microspheres were 2000 and 250, respectively, in 0.1 mL of solu-
tion. The microspheres, suspended in 10 mL of 0.9% saline, were inserted
into the filter from a 6F guiding catheter, set 5 cm proximal to the detach-
able filter.
After positioning the detachable filter, eachmicrospherewas carefully in-
jected into an aortic branch within 30 seconds using the 6F guiding catheter.
Next, residual microspheres in the guiding catheter were flushed out 3 times
with 10mLof 0.9% saline. After 5minutes, the polyethylenemeshfilter (53
mminwidth)was removed, and the number of capturedparticles on themesh
was counted through a microscope. Particles captured by the 53-mm mesh
filter (after passing the detachable filter) were defined as distal emboli.
The capture efficacy was calculated as follows: capture efficacy
(%) ¼ number of particles trapped by the filter (total particlesparticles
captured by the 53-mm mesh filter  particles left in syringe)/total
particles 3 100.
Thus, the greatest possible capture efficacy was 100%. Ten trials were
conducted for each microsphere size.
Implantation of Detachable Filter in Canine Model
Five normalmongrel dogs, weighing 25–30 kg each, were used in our ex-
periment. All dogs received humane care in compliance with the PrinciplesA, New detachable filter. B, Preloaded filter in the delivery sheath.
gery c December 2012
FIGURE 2. Various steps of the detachable filter retrieval. A, Approxima-
tion of a gooseneck snare to the filter. B and C, After capture of the hook of
the filter, the slidable sleeve is moved distally by pushing the 4F catheter,
resulting in folding of the filter. D and E, The folded filter device with 4F
catheter and gooseneck snare is retrieved into the 6F guiding catheter. Ar-
row, 6F guiding catheter; arrowhead, 4F catheter. Scale, 1 mm.
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Research and the Guide for the Care and Use of Laboratory Animals pre-
pared by the National Academy of Sciences and published by the National
InstitutesofHealth (Department ofHealth,Education, andWelfare,National
Institutes of Health publication 85-23, revised 1985). The study was ap-
proved by the Kyoto University Research Animal Review Committee and
conducted in accordance with the policies of Kyoto University.
Surgical preparation and anesthesia were performed as follows. The
dogs were premedicated with intramuscular injections of xylazine (40
mg) and atropine sulfate (50 mg). Subsequently, an intravenous catheter
was inserted into the right brachial vein, and propofol (100mg) was admin-
istered through the catheter. After inducing general anesthesia with pento-
barbital, the dogs weremaintained onventilator support with 1% isoflurane
in 100% oxygen. From the femoral artery, a 6F sheath catheter was placed
after systemic heparinization (100 U/kg). As described, the detachable fil-
ter was deployed into each targeted aortic branch under fluoroscopic guid-
ance (OEC 9800 Plus; General Electric, Fairfield, Conn) using a contrast
medium. Every 30 minutes, the contrast medium was injected through
the guiding catheter, and its flow through the filter was investigated. At 5
hours after deployment, the filter was retrieved by a gooseneck snare cath-
eter using the method previously shown.
Histologic Examination
After retrieval of the filter, the internal carotid artery of 1 canine was
removed, perfusion fixed with 10% buffered formalin, and embedded inThe Journal of Thoracic and Carplastic. The sample was then divided into 3 segments: distal, central (con-
taining the filter landing zone), and proximal. Each segment was stained
with hematoxylin and eosin (Cole-Parmer Instrument, Vernon Hills, Ill).
Statistical Analysis
All values are expressed as the mean standard deviation. The compar-
ison of the 2 groups was analyzed using the Wilcoxon signed rank test. All
statistical analyses were performed using the StatView software (SAS
Institute, Cary, NC).
RESULTS
In Vitro Studies
No technical failures occurred during any of the proce-
dures. The new detachable filter had a high capture efficacy,
with no statistically significant difference between the 2 mi-
crosphere sizes tested. The mean efficacy was 99.2% 
0.6% for the 100-mm microspheres and 99.4%  0.5%
for the 200-mm microspheres (P>.05).
In Vivo Studies
All new detachable filters were successfully deployed in
all aortic branches of 5 mongrel dogs. The J-shaped spring
coil wire attached to the filter accurately conducted the filter
to the targeted branch even when the branch was tortuous.
The activated clotting time was maintained at 150 to 250
seconds during the procedure. Angiography, performed ev-
ery 30 minutes for 5 hours, revealed smooth blood flow
through the filter without any signs of obstruction or throm-
boembolism in any of the 5 dogs (Figure 4). All filters were
completely retrieved using the gooseneck snare catheter
without aortic injury. The mean interval to achieve deploy-
ment was 9.0  3.3 minutes (range, 3–14), and the mean
duration for the retrieval was 9.6  6.2 minutes (range,
3–20). As we gained technical experience, both these times
progressively decreased.
Histologic Findings
Histologic analysis revealed complete preservation of the
endothelium and intima, even where the filter ring had at-
tached to the arterial wall. The media and adventitia were
also preserved.
DISCUSSION
Themain finding of the present study was that the detach-
able filter was successfully inserted and deployed in all
major branches of the aorta. After 5 hours, the device was
completely retrieved from the branches without any compli-
cations, such as extravasation, aortic dissection, or aortic
rupture. The efficacy of the detachable filter was also dem-
onstrated by the results from our in vitro studies. To the best
of our knowledge, this is the first report of a detachable filter
that can be applied to all major aortic branches with long-
term durability.
Endovascular repair with stent grafts offers an attractive
alternative to surgical repair for thoracic aortic aneurysms.1-3diovascular Surgery c Volume 144, Number 6 1401
FIGURE 3. Schematic representation of experimental flow model.
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a viable alternative to conventional open heart surgery in
selected high-risk patients.4 However, distal thromboembo-
lism has still been reported as a complication during these
procedures.5-8 Our efficient filter could contribute to
reduce the risk of distal thromboembolism. Moreover,
during endovascular surgery, such as aortic stent grafting
or transcatheter aortic valve implantation, no wires and
catheters are placed in the thoracic aorta when our
detachable filters are deployed directly into the aortic
branches. Thus, these detachable filters might not disrupt
the main endovascular surgery.
Commercially available distal protection filters provide
only short-term protection. This short lifespan might be
due to the relatively low fraction of pore space in each filter;
thus, thrombus captured by the filter might increase the re-
sistance to blood flow. Our new filter is composed ofFIGURE 4. Angiographic images revealing the new filter in an internal carotid
ment and C, its partial magnification. Arrow, ring of the filter; arrowhead, spri
1402 The Journal of Thoracic and Cardiovascular Surpolyester mesh and polyester yarn, 100 mm and 27 mm in di-
ameter, respectively. The proportion of pores in the mesh
filter is 62%. This construction might help to maintain
smooth blood flow and thus reduce the risk of distal
ischemia.
The coating on the filter is significant in preventing ob-
struction of the filter itself. The application of an heparin
coating alone on filter membranes might not be adequate
for maintaining long-term filter performance. To prevent
early occlusion, a new antithrombogenic coating system
that possesses the inhibitory functions of both thrombin
and platelet adhesion was introduced into the new detach-
able filter. This coating technology is based on the novel an-
tithrombogenic polymer developed by Toray Industries.
The polymer is able to reduce both the enzymatic activity
of thrombin and platelet adhesion in the same molecule,
and each function works independently on the materialartery. A, Schematic and B, angiographic representations of filter deploy-
ng coil; ICA, internal carotid artery.
gery c December 2012
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to the filter. This thin coating does not decrease the pore
size, yet provides the benefit of preventing thrombus
adhesion.
Another remarkable advantage of our detachable filter is
that its ring can be folded inward during retrieval. This fea-
ture would help to reduce the scattering of thrombus that
have attached to the edge of the filter. One of the shortcom-
ings of our detachable filter is that it required a relatively
long time to deploy and retrieve, although the time progres-
sively decreased with increased technical experience.
Several studies have shown that distal protection devices
are able to capture particles larger than the mesh pore
size.12-14 Our study showed similar results, because our
detachable filter was able to capture particles of both sizes
with high efficacy.
The detachable filters were successfully deployed into
each branch of the canine arteries and were retained in place
for 5 hours before retrieval. This suggests that our novel fil-
ter device might be tolerated for all endovascular surgeries.
Although our histologic analysis showed complete preser-
vation of the endothelium and intima, the possible risks of
iatrogenic injury and aortic dissection should be duly
considered.
Study Limitations
The present study had several potential limitations. First,
the anatomy of the aortic wall is not identical between hu-
mans and canines. The diameters of the canine arteries such
as the carotid, celiac, and supramesenteric arteries, are as
small as 6 mm; the differences are greater when canine
and human aortas are compared. The manipulation of the
filter device in a human arteriosclerotic aorta could be
much more complicated than that in a normal, undiseased
aorta. However, the angles between the aorta and the
branching arteries are convergent; therefore, the technical
difficulties in deploying and retrieving the detachable filter
could be assumed to be identical. The second limitation was
the length of the shaft. The form of the polyester mesh was
designed according to the length of the shaft. If the shaft
were shorter, the volume of the mesh filter would be re-
duced. The present study was also limited to a single filter
size. Filters of different shapes might produce different re-
sults; therefore, a more detailed examination is necessary toThe Journal of Thoracic and Cardetermine the feasibility of using detachable filters of dif-
ferent sizes.
In conclusion, we have developed a novel detachable fil-
ter, successfully deployed it for 5 hours in all major aortic
branches, and then retrieved it without any complications.
This novel filter could help prevent serious thromboembo-
lism during all types of endovascular surgery. More exper-
imental studies and device improvements are required
before this technique will be ready for clinical use in
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